journal article·2024-03-11

Tuning the Potency of Farnesol-Modified Polyethylenimine with Polyanionic Trans-Booster to Enhance DNA Delivery

Amarnath Praphakar Rajendran, Luis Carlos Morales, Daniel Nisakar Meenakshi Sundaram, Cezary Kucharski, Hasan Uludağ

Publisher page

Abstract

Low molecular weight polyethylenimine (PEI) based lipopolymers become an attractive strategy to construct nonviral therapeutic carriers with promising transfection efficiency and minimal toxicity. Herein, this paper presents the design and synthesis of novel farnesol (Far) conjugated PEI, namely PEI1.2k-SA-Far7. The polymers had quick DNA complexation, effective DNA unpacking (dissociation), and cellular uptake abilities when complexed with plasmid DNA. However, they were unable to provide robust transfection in culture, indicating inability of Far grafting to improve the transfection efficacy significantly. To overcome this limitation, the commercially available polyanionic Trans-Booster additive, which is capable of displaying electrostatic interaction with PEI1.2k-SA-Far7, has been used to enhance the uptake of pDNA polyplexes and transgene expression. pDNA condensation was successfully achieved in the presence of the Trans-Booster with more stable polyplexes, and in vitro transfection efficacy of the polyplexes was improved to be comparable to that obtained with an established reference reagent. The PEI1.2k-SA-Far7/pDNA/Trans-Booster ternary complex exhibited good compatibility with cells and minimal hemolysis activity. This work demonstrates the exemplary potency of using additives in polyplexes and the potential of resultant ternary complexes for effective pDNA delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta T6G 1H9, Canada

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada

Department of Biomedical Engineering and Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta T6G 2R3, Canada

References (65)

Show source-provided references
1. 10.3109/1061186x.2012.65524710.3109/1061186x.2012.655247 ↗
2. 10.1021/bm700731310.1021/bm7007313 ↗
3. 10.1016/j.ijpharm.2022.12248110.1016/j.ijpharm.2022.122481 ↗
4. 10.1016/j.ijpharm.2022.12248910.1016/j.ijpharm.2022.122489 ↗
5. 10.1002/mabi.20200004010.1002/mabi.202000040 ↗
6. 10.1039/d3tb00477e10.1039/d3tb00477e ↗
7. 10.1021/acs.biomac.8b0124810.1021/acs.biomac.8b01248 ↗
8. 10.3390/polym711151610.3390/polym7111516 ↗
9. 10.1016/j.progpolymsci.2010.11.00510.1016/j.progpolymsci.2010.11.005 ↗
10. 10.3390/polym1010108010.3390/polym10101080 ↗
11. 10.1038/mt.2012.18510.1038/mt.2012.185 ↗
12. 10.1016/j.jddst.2022.10401610.1016/j.jddst.2022.104016 ↗
13. 10.1021/acs.molpharmaceut.5b0057510.1021/acs.molpharmaceut.5b00575 ↗
14. 10.1016/j.jconrel.2011.04.01710.1016/j.jconrel.2011.04.017 ↗
15. 10.1016/j.biomaterials.2010.11.06110.1016/j.biomaterials.2010.11.061 ↗
16. 10.1021/bc050289f10.1021/bc050289f ↗
17. 10.1080/17435390.2022.215989110.1080/17435390.2022.2159891 ↗
18. 10.1080/1061186080190072810.1080/10611860801900728 ↗
19. 10.1016/j.cbi.2011.03.00910.1016/j.cbi.2011.03.009 ↗
20. 10.1111/j.1600-0536.1997.tb00192.x10.1111/j.1600-0536.1997.tb00192.x ↗
21. 10.3892/ijmm.2014.167910.3892/ijmm.2014.1679 ↗
22. Wang Z. · J. Pharm. Pharm. Sci. · 2003 · 6 · 95
23. 10.1007/s11745-997-0019-y10.1007/s11745-997-0019-y ↗
24. 10.1016/j.biomaterials.2012.09.04910.1016/j.biomaterials.2012.09.049 ↗
25. 10.1016/j.biomaterials.2009.04.04110.1016/j.biomaterials.2009.04.041 ↗
26. 10.1016/j.biomaterials.2009.01.05510.1016/j.biomaterials.2009.01.055 ↗
27. 10.1248/bpb.b12-0072810.1248/bpb.b12-00728 ↗
28. 10.1038/sj.gt.330188810.1038/sj.gt.3301888 ↗
29. 10.1016/j.cplett.2007.08.04610.1016/j.cplett.2007.08.046 ↗
30. 10.1007/s12272-008-1126-510.1007/s12272-008-1126-5 ↗
31. 10.1021/acsabm.2c0097810.1021/acsabm.2c00978 ↗
32. 10.1016/j.bmc.2009.12.01710.1016/j.bmc.2009.12.017 ↗
33. 10.1002/jbm.a.3683710.1002/jbm.a.36837 ↗
34. 10.1039/c4tb02101k10.1039/c4tb02101k ↗
35. 10.1016/j.actbio.2022.06.03010.1016/j.actbio.2022.06.030 ↗
36. 10.1002/jbm.a.3721410.1002/jbm.a.37214 ↗
37. 10.1016/j.actbio.2016.01.02510.1016/j.actbio.2016.01.025 ↗
38. 10.1016/j.actbio.2011.01.02710.1016/j.actbio.2011.01.027 ↗
39. 10.1021/mp050007t10.1021/mp050007t ↗
40. 10.1016/j.ymthe.2004.06.29310.1016/j.ymthe.2004.06.293 ↗
41. 10.1002/mabi.20140046310.1002/mabi.201400463 ↗
42. 10.1021/bm034083y10.1021/bm034083y ↗
43. 10.1006/bioo.1997.106610.1006/bioo.1997.1066 ↗
44. 10.1021/acsomega.9b0341310.1021/acsomega.9b03413 ↗
45. 10.1016/j.jconrel.2023.07.01910.1016/j.jconrel.2023.07.019 ↗
46. 10.1016/j.ijpharm.2016.07.04910.1016/j.ijpharm.2016.07.049 ↗
47. 10.1038/sj.gt.330123010.1038/sj.gt.3301230 ↗
48. 10.1038/sj.gt.330090010.1038/sj.gt.3300900 ↗
49. 10.1016/j.jconrel.2006.03.01310.1016/j.jconrel.2006.03.013 ↗
50. 10.1007/s11095-011-0545-z10.1007/s11095-011-0545-z ↗
51. 10.1016/j.colsurfb.2015.08.02510.1016/j.colsurfb.2015.08.025 ↗
52. 10.1016/j.jconrel.2006.04.01410.1016/j.jconrel.2006.04.014 ↗
53. 10.1016/j.addr.2009.08.00410.1016/j.addr.2009.08.004 ↗
54. 10.1021/mp200379710.1021/mp2003797 ↗
55. 10.1016/j.biomaterials.2007.02.02710.1016/j.biomaterials.2007.02.027 ↗
56. 10.1039/C5TB01225B10.1039/C5TB01225B ↗
57. 10.1002/app.5132310.1002/app.51323 ↗
58. 10.1073/pnas.19258149910.1073/pnas.192581499 ↗
59. Jiang G. · Yaoxue Xuebao · 2006 · 41 · 439
60. 10.1016/j.biomaterials.2003.10.00410.1016/j.biomaterials.2003.10.004 ↗
61. 10.1016/j.ejpb.2022.12.00210.1016/j.ejpb.2022.12.002 ↗
62. 10.1002/advs.20170017510.1002/advs.201700175 ↗
63. 10.1021/acsami.7b0603110.1021/acsami.7b06031 ↗
64. 10.1016/j.carbpol.2018.08.06310.1016/j.carbpol.2018.08.063 ↗
65. 10.1186/1477-3155-10-710.1186/1477-3155-10-7 ↗